Skip Nav Destination
Issues
15 January 2017
-
Cover Image
Cover Image
The cover shows a tumor subclone derived from a clinical glioblastoma sample giving rise to multinucleated giant cells in vitro. Immunofluorescence depicts expression of βIII-tubulin (green) and glial fibrillary acidic protein (GFAP, red). Cellular nuclei were DAPI stained. For details, see the article by Reinartz and colleagues on page 562 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma
Harpreet Singh; Michael Brave; Julia A. Beaver; Joyce Cheng; Shenghui Tang; Eias Zahalka; Todd R. Palmby; Rajesh Venugopal; Pengfei Song; Qi Liu; Chao Liu; Jingyu Yu; Xiao Hong Chen; Xing Wang; Yaning Wang; Paul G. Kluetz; Selena R. Daniels; Elektra J. Papadopoulos; Rajeshwari Sridhara; Amy E. McKee; Amna Ibrahim; Geoffrey Kim; Richard Pazdur
Molecular Pathways
Review
Cancer Therapy: Clinical
Branched Chain RNA In Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
Philip J. Saylor; Richard J. Lee; Kshitij S. Arora; Vikram Deshpande; Rong Hu; Kara Olivier; Erika Meneely; Miguel N. Rivera; David T. Ting; Chin-Lee Wu; David T. Miyamoto
Personalized Medicine and Imaging
Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer
Heather A. Parsons; Julia A. Beaver; Ashley Cimino-Mathews; Siraj M. Ali; Jennifer Axilbund; David Chu; Roisin M. Connolly; Rory L. Cochran; Sarah Croessmann; Travis A. Clark; Christopher D. Gocke; Stacie C. Jeter; Mark R. Kennedy; Josh Lauring; Justin Lee; Doron Lipson; Vincent A. Miller; Geoff A. Otto; Gary L. Rosner; Jeffrey S. Ross; Shannon Slater; Philip J. Stephens; Dustin A. VanDenBerg; Antonio C. Wolff; Lauren E. Young; Daniel J. Zabransky; Zhe Zhang; Jane Zorzi; Vered Stearns; Ben H. Park
Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
Anne Trinh; Kari Trumpi; Felipe De Sousa E Melo; Xin Wang; Joan H. de Jong; Evelyn Fessler; Peter J.K. Kuppen; Marlies S. Reimers; Marloes Swets; Miriam Koopman; Iris D. Nagtegaal; Marnix Jansen; Gerrit K.J. Hooijer; George J.A. Offerhaus; Onno Kranenburg; Cornelis J. Punt; Jan Paul Medema; Florian Markowetz; Louis Vermeulen
Estrogen Receptor Binding (18F-FES PET) and Glycolytic Activity (18F-FDG PET) Predict Progression-Free Survival on Endocrine Therapy in Patients with ER+ Breast Cancer
Brenda F. Kurland; Lanell M. Peterson; Jean H. Lee; Erin K. Schubert; Erin R. Currin; Jeanne M. Link; Kenneth A. Krohn; David A. Mankoff; Hannah M. Linden
Cancer Therapy: Preclinical
Follicle-Stimulating Hormone Receptor Is Expressed by Most Ovarian Cancer Subtypes and Is a Safe and Effective Immunotherapeutic Target
Alfredo Perales-Puchalt; Nikolaos Svoronos; Melanie R. Rutkowski; Michael J. Allegrezza; Amelia J. Tesone; Kyle K. Payne; Jayamanna Wickramasinghe; Jenny M. Nguyen; Shane W. O'Brien; Kiranmai Gumireddy; Qihong Huang; Mark G. Cadungog; Denise C. Connolly; Julia Tchou; Tyler J. Curiel; Jose R. Conejo-Garcia
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors
Adrian M. Seifert; Shan Zeng; Jennifer Q. Zhang; Teresa S. Kim; Noah A. Cohen; Michael J. Beckman; Benjamin D. Medina; Joanna H. Maltbaek; Jennifer K. Loo; Megan H. Crawley; Ferdinand Rossi; Peter Besmer; Cristina R. Antonescu; Ronald P. DeMatteo
Preclinical Assessment of CD171-Directed CAR T-cell Adoptive Therapy for Childhood Neuroblastoma: CE7 Epitope Target Safety and Product Manufacturing Feasibility
Annette Künkele; Agne Taraseviciute; Laura S. Finn; Adam J. Johnson; Carolina Berger; Olivia Finney; Cindy A. Chang; Lisa S. Rolczynski; Christopher Brown; Stephanie Mgebroff; Michael Berger; Julie R. Park; Michael C. Jensen
Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
Hong Liu; Yiyang Xu; Jingyi Xiang; Li Long; Shon Green; Zhiyuan Yang; Bryan Zimdahl; Jingwei Lu; Neal Cheng; Lucas H. Horan; Bin Liu; Su Yan; Pei Wang; Juan Diaz; Lu Jin; Yoko Nakano; Javier F. Morales; Pengbo Zhang; Lian-xing Liu; Binnaz K. Staley; Saul J. Priceman; Christine E. Brown; Stephen J. Forman; Vivien W. Chan; Cheng Liu
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
Elizabeth L. McMichael; Alena Cristina Jaime-Ramirez; Kristan D. Guenterberg; Eric Luedke; Lakhvir S. Atwal; Amanda R. Campbell; Zhiwei Hu; Armika S. Tatum; Sri Vidya Kondadasula; Xiaokui Mo; Susheela Tridandapani; Mark Bloomston; E. Christopher Ellison; Terence M. Williams; Tanios Bekaii-Saab; William E. Carson, III
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Yajing Liu; Monika L. Burness; Rachel Martin-Trevino; Joey Guy; Shoumin Bai; Ramdane Harouaka; Michael D. Brooks; Li Shang; Alex Fox; Tahra K. Luther; April Davis; Trenton L. Baker; Justin Colacino; Shawn G. Clouthier; Zhi-ming Shao; Max S. Wicha; Suling Liu
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer
Benjamin H. Lok; Eric E. Gardner; Valentina E. Schneeberger; Andy Ni; Patrice Desmeules; Natasha Rekhtman; Elisa de Stanchina; Beverly A. Teicher; Nadeem Riaz; Simon N. Powell; John T. Poirier; Charles M. Rudin
Preclinical Benefit of Hypoxia-Activated Intra-arterial Therapy with Evofosfamide in Liver Cancer
Rafael Duran; Sahar Mirpour; Vasily Pekurovsky; Shanmugasundaram Ganapathy-Kanniappan; Cory F. Brayton; Toby C. Cornish; Boris Gorodetski; Juvenal Reyes; Julius Chapiro; Rüdiger E. Schernthaner; Constantine Frangakis; MingDe Lin; Jessica D. Sun; Charles P. Hart; Jean-François Geschwind
ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet–associated Colon Cancer
Reba Mustafi; Urszula Dougherty; Devkumar Mustafi; Fatma Ayaloglu-Butun; Michelle Fletcher; Sarbani Adhikari; Farhana Sadiq; Katherine Meckel; Haider I. Haider; Abdurahman Khalil; Joel Pekow; Vani Konda; Loren Joseph; John Hart; Alessandro Fichera; Yan Chun Li; Marc Bissonnette
Biology of Human Tumors
Functional Subclone Profiling for Prediction of Treatment-Induced Intratumor Population Shifts and Discovery of Rational Drug Combinations in Human Glioblastoma
Roman Reinartz; Shanshan Wang; Sied Kebir; Daniel J. Silver; Anja Wieland; Tong Zheng; Marius Küpper; Laurèl Rauschenbach; Rolf Fimmers; Timothy M. Shepherd; Daniel Trageser; Andreas Till; Niklas Schäfer; Martin Glas; Axel M. Hillmer; Sven Cichon; Amy A. Smith; Torsten Pietsch; Ying Liu; Brent A. Reynolds; Anthony Yachnis; David W. Pincus; Matthias Simon; Oliver Brüstle; Dennis A. Steindler; Björn Scheffler
Author Choice
Genetic and Methylation-Induced Loss of miR-181a2/181b2 within chr9q33.3 Facilitates Tumor Growth of Cervical Cancer through the PIK3R3/Akt/FoxO Signaling Pathway
Qian Mei; Xiang Li; Kang Zhang; Zhiqiang Wu; Xiaolei Li; Yuanguang Meng; Mingzhou Guo; Guangbin Luo; Xiaobing Fu; Weidong Han
Alternative Lengthening of Telomeres and Loss of DAXX/ATRX Expression Predicts Metastatic Disease and Poor Survival in Patients with Pancreatic Neuroendocrine Tumors
Aatur D. Singhi; Ta-Chiang Liu; Justin L. Roncaioli; Dengfeng Cao; Herbert J. Zeh; Amer H. Zureikat; Allan Tsung; J. Wallis Marsh; Kenneth K. Lee; Melissa E. Hogg; Nathan Bahary; Randall E. Brand; Kevin M. McGrath; Adam Slivka; Kristi L. Cressman; Kimberly Fuhrer; Roderick J. O'Sullivan
Corrections
Retraction
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds